{"id":"W3135371333","doi":"10.3233/kca-210110","title":"Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis)","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; St Joseph's Health Centre; University of Ottawa; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Western University; Princess Margaret Cancer Centre; University of Calgary; Centre hospitalier universitaire de Québec; London Health Sciences Centre; Alberta Health Services; McMaster University; University of Manitoba; Juravinski Cancer Centre; Université Laval; University of Alberta","funders":"Genentech; Ipsen; Astellas Pharma; Eisai; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Exelixis; GlaxoSmithKline","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Kidney cancer; Internal medicine; Cancer; Oncology; Tyrosine-kinase inhibitor; Population; Urology; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003523847,0.0001855758,0.0004535638,0.0006208876,0.0006410662,0.001067449,0.0005389472,0.0004031818,0.002470037],"category_scores_gemma":[0.01176773,0.0001335837,0.0003931398,0.002401715,0.0004984592,0.0005802106,0.000789837,0.0004384828,0.0004563196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007190917,"about_ca_system_score_gemma":0.006598365,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3911007,"about_ca_topic_score_gemma":0.4063764,"domain_scores_codex":[0.9974859,0.0006929868,0.0003146669,0.000286493,0.0009513324,0.0002686667],"domain_scores_gemma":[0.9873076,0.002516389,0.004607245,0.000428931,0.003131141,0.00200862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008473475,0.0004525366,0.912169,0.0007259302,0.0003017051,0.0003663078,0.001642796,0.001037993,0.0006552432,0.0001542877,0.01143365,0.06258707],"study_design_scores_gemma":[0.0009284683,0.001727033,0.9789514,0.0001584815,0.000261721,0.0003906774,0.001178902,0.001082563,0.0005615351,0.0000590161,0.01464074,0.00005953362],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761595,0.004310177,0.0001957476,0.001397757,0.00002158437,0.0001929755,0.01382523,0.00002922828,0.003867774],"genre_scores_gemma":[0.9871532,0.001735955,0.0004330152,0.0005668967,0.00004102187,0.0000714459,0.009304246,0.00001629554,0.0006777945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6088993,"threshold_uncertainty_score":0.7776485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02726936905650948,"score_gpt":0.2753342238878853,"score_spread":0.2480648548313758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}